Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03XKJ
|
|||
Former ID |
DNC013319
|
|||
Drug Name |
N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide
|
|||
Synonyms |
CHEMBL396267; N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H17ClN2O2
|
|||
Canonical SMILES |
C1=CC(=CC=C1CNCC(=O)N)OCC2=CC=C(C=C2)Cl
|
|||
InChI |
1S/C16H17ClN2O2/c17-14-5-1-13(2-6-14)11-21-15-7-3-12(4-8-15)9-19-10-16(18)20/h1-8,19H,9-11H2,(H2,18,20)
|
|||
InChIKey |
OIWXOGDFIRHEKD-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoa... J Med Chem. 2007 Oct 4;50(20):4909-16. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.